- Seasonal influenza activity remains low nationally.
- Influenza A(H1N1)pdm09, A(H3N2), and B viruses are all co-circulating.
- The percentage of visits for respiratory illness (ILI) remained stable and is below the national baseline.
- ILI activity varied by region, with no jurisdictions experiencing moderate, high, or very high activity.
- The weekly hospitalization rate for laboratory-confirmed influenza was 0.1 per 100,000 population.
- 0.04% of deaths were attributed to influenza.
- No influenza-associated pediatric deaths were reported.
- Antigenic and genetic characterization of circulating influenza viruses is ongoing.
- Susceptibility testing showed some reduced or highly reduced inhibition by antiviral medications.
- CDC recommends annual flu vaccination and antiviral treatment for high-risk patients.
- Integrated information about COVID-19, flu, and RSV activity is provided on a weekly basis.
- Workplaces may monitor health-related absenteeism through the National Institute for Occupational Safety and Health.
- International influenza surveillance and collaborative efforts are in place with WHO and other organizations.